Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perfluorohexyloctane eye drops for dry eye after corneal refractive surgery
ChiCTR2600132557Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University Eye Hospital
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of perfluorohexyloctane in dry eye syndrome (DED) (2 arms), sponsored by Tianjin Medical University Eye Hospital. Primary endpoints: VAS score for dry-eye sensation and Total corneal fluorescein staining score. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
perfluorohexyloctane
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2600132557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132557.